Cargando…

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes

Bone marrow (BM) mesenchymal stem/stromal cells (MSCs) are vital in hematopoiesis. Whether BM-MSCs alter their characteristics in Myelodysplastic Syndromes (MDS) is still controversial. We characterized MSCs of de novo MDS patients in Sri Lanka who have not been reported previously in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathnayake, A. J. I. S., Goonasekera, H. W. W., Dissanayake, V. H. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021885/ https://www.ncbi.nlm.nih.gov/pubmed/27660743 http://dx.doi.org/10.1155/2016/8012716

Ejemplares similares

Identification of Novel Insertions and Deletions in Haematopoietic Stem/Progenitor Cells in de novo Myelodysplastic Syndromes
por: Bandara, Manoj, et al.
Publicado: (2021)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
por: Elnahass, Yasser, et al.
Publicado: (2018)

The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome
por: Zheng, Likun, et al.
Publicado: (2022)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
por: Saumell, Sílvia, et al.
Publicado: (2015)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
por: Anwar, Nida, et al.
Publicado: (2017)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes()
por: Vu, Minh Phuong, et al.
Publicado: (2022)

Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
por: Mattiucci, Domenico, et al.
Publicado: (2018)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS
por: Manola, K., et al.
Publicado: (2022)

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
por: Ciabatti, Elena, et al.
Publicado: (2017)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
por: Mahmood, Rafia, et al.
Publicado: (2018)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
por: Aghoutane, Yossra, et al.
Publicado: (2023)

De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences
por: Leone, Giuseppe, et al.
Publicado: (2022)

Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome
por: Corrêa de Souza, Daiane, et al.
Publicado: (2014)

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor
por: Ohyashiki, Kazuma, et al.
Publicado: (1989)

Accurate Detection of Uniparental Disomy and Microdeletions by SNP Array Analysis in Myelodysplastic Syndromes with Normal Cytogenetics
por: Heinrichs, Stefan, et al.
Publicado: (2009)

The Mesenchymal Niche in Myelodysplastic Syndromes
por: Friedrich, Chloé, et al.
Publicado: (2022)

Multicenter Validation Study of a Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes
por: Armand, Philippe, et al.
Publicado: (2009)

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores
por: Căzăceanu, O, et al.
Publicado: (2014)

Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
por: Narayanan, Santhosh
Publicado: (2017)

Cytogenetic characteristics of 665 patients with myelodysplastic syndrome in China: A single-center report
por: Wang, Xueying, et al.
Publicado: (2021)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma
por: Choi, Hayoung, et al.
Publicado: (2020)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes
por: Fei, Cheng-Ming, et al.
Publicado: (2018)

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
por: Sozzi, G., et al.
Publicado: (1990)

Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group
por: Heilig, Christoph E, et al.
Publicado: (2010)

3D Telomere Structure Analysis to Detect Genomic Instability and Cytogenetic Evolution in Myelodysplastic Syndromes
por: Rangel-Pozzo, Aline, et al.
Publicado: (2019)

Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma
por: Kalantri, Shreyas, et al.
Publicado: (2023)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes
por: Ostendorf, Benjamin N., et al.
Publicado: (2018)

Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component
por: Platte, Victoria, et al.
Publicado: (2022)

Sonic Hedgehog Produced by Bone Marrow-Derived Mesenchymal Stromal Cells Supports Cell Survival in Myelodysplastic Syndrome
por: Zou, Jixue, et al.
Publicado: (2015)

Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
por: Wu, Yuenv, et al.
Publicado: (2017)

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities
por: L’Abbate, Alberto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3uui0dv5h9h8he9jori5iqqv7i